Picosecond Laser

In brief: A picosecond laser is a family of devices that delivers energy in very short, picosecond-range pulses. The strongest clinical use is fragmentation of selected tattoo pigments; there are also studies of benign pigment and fractional handpieces for textural concerns. The word “picosecond,” however, does not prove safety, superiority, fewer sessions, or suitability for every skin type. Decisions require a diagnosis, exact device and model, wavelength, handpiece, intended use, skin type, and individual risk assessment.

Definition

A picosecond is one trillionth of a second. Picosecond laser systems can deliver energy within this very short interval. A short pulse can produce strong photoacoustic or photomechanical effects in a target pigment, but tissue interaction is not purely mechanical and thermal injury is not zero. Wavelength influences which chromophore absorbs energy, pulse characteristics and spot size influence distribution in tissue, and the handpiece changes how energy is focused.

For that reason, “picosecond laser” is not enough to describe a product or a medical decision. Systems in the same category may have different wavelengths, accessories, energy ranges, and regulatory indications. An FDA 510(k) decision for one device does not make every picosecond laser “FDA approved.” In Türkiye, the exact manufacturer, model, serial number, intended use, and Product Tracking System record also need separate verification.

How It Is Performed

A safe pathway starts with diagnosis rather than device selection. For a tattoo, assessment includes colours, whether pigment is professional or cosmetic, previous treatment, scarring, and allergic symptoms. For a pigmented skin lesion, benign status must be established before cosmetic treatment. A changing, bleeding, irregular, or uncertain lesion should not be “removed” with a laser before appropriate specialist assessment.

The consultation reviews skin type, tanning and sun exposure, tendency to post-inflammatory colour change, active infection, healing and keloid history, immune status, pregnancy or breastfeeding, cold-sore history, prescription and non-prescription medicines, and supplements. Patients should not stop medication themselves; any necessary change is coordinated with the prescriber.

If treatment is considered, the exact device, wavelength, handpiece, and indication are verified. Expected benefit, uncertainty, alternatives, the possible need for multiple sessions, incomplete clearance, and colour-change risk are discussed. Wavelength-specific eye protection is essential for the patient, operator, and anyone in the room. Settings, need for a test area, cooling, comfort measures, and follow-up come from the manufacturer’s instructions and individual assessment; a public webpage cannot provide personal parameters.

Indications

Tattoo pigment: Tattoo removal is the most studied use. Systematic reviews report meaningful lightening in some black and blue pigments, but many studies are small, non-comparative, or at risk of bias. Colour, pigment chemistry, density, depth, tattoo age, anatomical site, skin type, immune response, and previous treatment all affect the outcome. Some white, flesh-coloured, red, or iron-oxide cosmetic pigments may darken unexpectedly.

Benign pigmented lesions: Specific devices and wavelengths may have regulatory clearance or clinical evidence for selected epidermal pigmented lesions. This does not mean that melanocytic tumours or undiagnosed marks should receive cosmetic laser treatment. Diagnosis and the exact device indication come first.

Melasma: Melasma is chronic, recurrent, and capable of worsening after inflammation. A 2026 meta-analysis of randomised trials reported that a selected 755-nm picosecond alexandrite approach was not superior to triple-combination topical therapy and may produce more post-inflammatory hyperpigmentation; certainty was limited. Picosecond laser is therefore not a universal first-line treatment or cure for melasma.

Acne scars and texture: Studies of fractional handpieces suggest potential improvement in atrophic acne scars and texture. Scar type, depth, active acne, pigment risk, and alternatives must be assessed before discussing treatment, and neither a fixed result nor a fixed session count is defensible.

Contraindications

Active infection or open skin, recent sunburn or marked tanning, an undiagnosed pigmented lesion, uncontrolled photosensitivity, impaired healing, an active tattoo reaction, or unrealistic expectations may require deferral or another evaluation. Keloid history, immune suppression, pregnancy or breastfeeding, cold-sore history, a previous laser complication, and medicines including isotretinoin are handled according to procedure type, current evidence, and individual risk rather than a universal internet rule.

If a tattoo is raised, itchy, inflamed, or associated with systemic allergy symptoms, fragmentation of pigment may aggravate the reaction. Cosmetic eyebrow or eyeliner pigments need discussion of paradoxical darkening and special eye protection. A reassuring test spot does not prove that treatment of the entire area will be associated with potential risks.

Duration and Recovery

Tattoo lightening is not completed at the moment of treatment; clearance of fragmented pigment develops over time and varies between people. There is no universal session number or interval. Early whitening, redness, tenderness, swelling, pinpoint bleeding, blistering, or crusting may occur. Fractional procedures may produce a temporary dot pattern and rough texture. Social downtime depends on device, settings, area, and individual response.

Written aftercare is provided after treatment. Protecting the area from trauma and photoprotection are central principles, while product and medication advice varies by person. Escalating or severe pain, extensive blistering, rapidly spreading redness or warmth, drainage, fever, breathing difficulty, widespread hives, eye pain, or visual change require prompt in-person medical assessment.

Risks and Adverse Effects

Common reported reactions include temporary redness, swelling, tenderness, pinpoint bleeding, and crusting. More important risks include burns, infection, prolonged erythema, hyperpigmentation or hypopigmentation, permanent scarring, texture change, and incomplete or uneven clearance. Pigment change may be more likely in darker or recently tanned skin; a picosecond pulse does not eliminate that risk.

The composition of tattoo ink is often uncertain. Fragmenting pigment may trigger a local or systemic allergic reaction. Paradoxical darkening can occur in cosmetic pigments. Incorrect eye protection can cause serious ocular injury. These risks support treatment by an appropriately trained healthcare professional using safeguards specific to the exact device.

Comparison

Picosecond systems generate shorter pulses than nanosecond Q-switched systems and may create smaller fragments in selected pigments. A theoretical advantage is not universal clinical superiority across every colour, device, and patient. A 2016 systematic review described the evidence favouring picosecond tattoo removal as sparse and noted medium-to-high risk of bias in much of the literature. Later reviews suggest advantages for some outcomes, while effectiveness and adverse effects still vary with wavelength, pigment, and study design.

The decision should not be reduced to “picosecond versus Q-switched.” The exact platform, wavelength, pigment colour, diagnosis, skin type, operator training, eye protection, follow-up capacity, and the option not to treat all matter.

Alternatives and Combination Procedures

For a tattoo, alternatives may include waiting or no treatment, cover-up, surgical opinion for selected small tattoos, or a nanosecond system with a verified model and indication. Each option has different trade-offs around scarring, pigment change, and incomplete results. Acne-scar alternatives may include microneedling, radiofrequency microneedling, fractional ablative or non-ablative lasers, subcision, and methods selected for a particular scar. For melasma, diagnosis, consistent photoprotection, and clinician-managed topical options usually remain central.

Combination treatment is not automatically better. Closely timed energy, peel, injectable, or medication procedures may alter total inflammation, pigment risk, infection risk, and healing. Sequence and interval are individualized only after every procedure and product is known.

Related Terms

• Q-switched Nd:YAG laser
• Fractional CO2 laser
• IPL
• Tattoo removal
• Acne-scar treatment

Frequently Asked Questions

Will a picosecond laser remove a tattoo completely? Complete clearance vary. Some pigment can remain resistant, change colour, or lighten only partially.

Does it always require fewer sessions? Some studies report an advantage for selected pigments, but a fixed percentage or session reduction cannot be applied to every device and tattoo.

Is it safe in darker skin? Treatment may be possible with an appropriate device and settings, but burn and pigment-change risks remain. The label “picosecond” is not a safety guarantee.

Can candidacy be decided from a photograph? A photograph can show colour and location, but it cannot reliably identify pigment composition, lesion diagnosis, depth, or personal risk. In-person assessment is required.

Dr Hamza Gemici's View

“Before discussing brand or speed claims, I verify the diagnosis, nature of the pigment, exact device, and the person’s pigment risk. A primum non nocere approach may mean a test area, deferral, no treatment, or referral to another specialist.”

— Dr Hamza Gemici, Medical Aesthetics Physician